Selenium supplementation for the primary prevention of cardiovascular disease
Source: Cochrane
Area: Evidence > Complementary Medicine
Background
Selenium is a key component of a number of selenoproteins which protect against oxidative stress and have the potential to prevent chronic diseases including cardiovascular disease (CVD). However, observational studies have shown inconsistent associations between selenium intake and CVD risk; in addition, there is concern around a possible increased risk of type 2 diabetes with high selenium exposure.
Objectives
To determine the effectiveness of selenium only supplementation for the primary prevention of CVD and examine the potential adverse effect of type 2 diabetes.
Search methods
The following electronic databases were searched: the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 10 of 12, October 2012) on The Cochrane Library; MEDLINE (Ovid) (1946 to week 2 October 2012); EMBASE Classic + EMBASE (Ovid) (1947 to 2012 Week 42); CINAHL (EBSCO) (to 24 October 2012); ISI Web of Science ...
Source: NeLM - Cardiovascular Medicine - Category: Cardiology Source Type: news
More News: Alternative and Complementary Therapies | Cardiology | Cardiovascular | Complementary Medicine | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Science | Selenium | Study